RPG LifeScience.

{
  "main_header": {
    "sid": 456242,
    "name": "RPG LifeScience.",
    "stock_name": "RPG LifeScience.",
    "full_name": "RPG Life Sciences Ltd",
    "name_url": "stocks-analysis/rpg-lifescience",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,978.90",
    "chg": -2.5,
    "chgp": "-0.13%",
    "dir": -1,
    "prev_price": "1,981.40",
    "mcapval": "3,272.91 Cr",
    "mcap": "Small Cap",
    "scripcode": 532983,
    "symbol": "RPGLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE105J01010",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": "10.7 k",
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rpg-lifescience-456242-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "RPG Life Sciences Falls 5.89%: 3 Key Factors Behind the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-falls-589-3-key-factors-behind-the-weekly-decline-3813171",
        "imagepath": "",
        "date": "2026-01-31 17:08:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jan:</strong> Q3 FY26 results reveal 40% profit plunge</p>\n                    <p><strong>28 Jan:</strong> Stock hits intraday low amid heavy selling pressure</p>\n                    <p><strong>29 Jan:</strong> Downgrade to Sell as quality metrics weaken</p>\n                    <p><strong>30 Jan:</strong> Minor recovery closes week at Rs.2,009.60 (-0.31% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,135.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,009.60</div..."
      },
      {
        "title": "RPG Life Sciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rpg-life-sciences-ltd-is-rated-sell-3811203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/RPGLifeSciences_mojoScore_3811203.png",
        "date": "2026-01-30 10:10:03",
        "description": "RPG Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "RPG Life Sciences Ltd Downgraded to Sell as Quality Metrics Weaken",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-downgraded-to-sell-as-quality-metrics-weaken-3808586",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/RPGLifeSciences_qualitydot_3808586.png",
        "date": "2026-01-29 08:00:10",
        "description": "RPG Life Sciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its quality rating downgraded from 'Good' to 'Average' as of 16 January 2026, prompting a shift in its Mojo Grade from Hold to Sell. This change reflects a nuanced deterioration in several fundamental business parameters, despite the company’s strong historical returns and robust capital efficiency metrics."
      },
      {
        "title": "Are RPG Life Sciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-rpg-life-sciences-ltd-latest-results-good-or-bad-3808237",
        "imagepath": "",
        "date": "2026-01-28 19:17:18",
        "description": "RPG Life Sciences Ltd's latest financial results for Q3 FY26 indicate a notable shift in operational performance. The company reported net sales of ₹180.03 crores, reflecting a marginal decline of 0.91% from the previous quarter. This stability in revenue contrasts sharply with the significant drop in net profit, which fell to ₹22.13 crores, marking a contraction of 39.95% quarter-on-quarter. The profit after tax (PAT) margin also experienced a substantial decrease, dropping to 12.29%, down from 20.28% in the prior quarter.\n\nThe operating profit showed a slight improvement, with an operating margin of 22.09%, which is an increase of 61 basis points from the previous quarter. However, this positive aspect is overshadowed by the dramatic decline in gross profit margin, which fell to 19.16%, representing a significant compression of 1,093 basis points. This decline raises concerns regarding the company's prici..."
      },
      {
        "title": "RPG Life Sciences Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-hits-intraday-low-amid-price-pressure-3807056",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/RPGLifeSciences_priceRelatedfactors_3807056.png",
        "date": "2026-01-28 09:47:03",
        "description": "RPG Life Sciences Ltd experienced a significant intraday decline on 28 Jan 2026, touching a low of Rs 1,912.7, reflecting an 8.88% drop from previous levels. The stock underperformed its sector and broader market indices, continuing a three-day losing streak amid persistent selling pressure and subdued market sentiment."
      },
      {
        "title": "RPG Life Sciences Q3 FY26: Profit Plunges 40% as Margin Pressures Mount",
        "link": "https://www.marketsmojo.com/news/result-analysis/rpg-life-sciences-q3-fy26-profit-plunges-40-as-margin-pressures-mount-3806529",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/RPGLifeSciences_quaterlyResult_3806529.png",
        "date": "2026-01-27 22:30:55",
        "description": "RPG Life Sciences Limited reported a sharp decline in profitability for the third quarter of FY2026, with net profit tumbling 39.95% quarter-on-quarter to ₹22.13 crores, down from ₹36.85 crores in Q2 FY26. The Mumbai-based pharmaceutical company, with a market capitalisation of ₹3,483 crores, witnessed its stock decline 2.16% to ₹2,089.30 following the results announcement, reflecting investor concerns over deteriorating margins and sequential profit compression despite stable revenue performance."
      },
      {
        "title": "RPG Life Sciences Declines 7.32%: Technical Downturn and Valuation Concerns Shape Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-declines-732-technical-downturn-and-valuation-concerns-shape-week-3803698",
        "imagepath": "",
        "date": "2026-01-24 17:09:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>19 Jan:</strong> Downgrade to Sell rating by MarketsMOJO citing bearish technicals and valuation concerns</p>\n                    <p><strong>19 Jan:</strong> Technical momentum shifts to bearish with multiple indicators signalling weakness</p>\n                    <p><strong>22 Jan:</strong> Minor recovery with a 0.30% gain amid broader market rebound</p>\n                    <p><strong>23 Jan:</strong> Sharp decline of 3.20% on heavy volume closes the week lower</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,295.45</div></div>\n                    <div ..."
      },
      {
        "title": "Why is RPG Life Sciences Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-rpg-life-sciences-ltd-fallingrising-3802706",
        "imagepath": "",
        "date": "2026-01-24 00:50:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock’s downward trajectory over the past week and month has been pronounced, with losses of 7.22% and 9.53% respectively, significantly exceeding the Sensex’s declines of 2.43% and 4.66% over the same periods. Year-to-date, RPG Life Sciences has fallen 7.87%, nearly double the Sensex’s 4.32% drop. Even over the last year, the stock has marginally declined by 1.33%, contrasting with the Sensex’s 6.56% gain. Despite this, the company’s longer-term performance remains robust, with three- and five-year returns of 148.29% and 380.94%, far outpacing the benchmark’s 33.80% and 66.82% respectively.</p>\n<p>On the day of the decline, the stock underperformed its sector by 2.02%, hitting an intraday low of ₹2,125.05, a 3.67% drop from the pr..."
      },
      {
        "title": "When is the next results date for RPG Life Sciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-rpg-life-sciences-ltd-3799038",
        "imagepath": "",
        "date": "2026-01-21 23:16:21",
        "description": "The next results date for RPG Life Sciences Ltd is scheduled for January 27, 2026...."
      }
    ],
    "total": 327,
    "sid": "456242",
    "stock_news_url": "https://www.marketsmojo.com/news/rpg-life-sciences-456242"
  },
  "announcements": [
    {
      "details": "RPG Life Sciences Limited has submitted to the Exchange a copy of disclosure of Related Party Transactions for the half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "RPG Life Sciences Limited - Other General Purpose",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "RPG Life Sciences Limited has informed the Exchange regarding 'In terms of the Regulation 30 read with Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter and half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "RPG Life Sciences Limited - Updates",
      "datetime": "01-Nov-2019"
    },
    {
      "details": "RPG Life Sciences Limited has informed the Exchange regarding Board meeting held on October 30, 2019.",
      "source": "NSE",
      "caption": "RPG Life Sciences Limited - Outcome of Board Meeting",
      "datetime": "31-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "RPG Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 27 Jun 25",
          "dt": "2025-06-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

RPG Life Sciences Falls 5.89%: 3 Key Factors Behind the Weekly Decline

2026-01-31 17:08:22

Key Events This Week

27 Jan: Q3 FY26 results reveal 40% profit plunge

28 Jan: Stock hits intraday low amid heavy selling pressure

29 Jan: Downgrade to Sell as quality metrics weaken

30 Jan: Minor recovery closes week at Rs.2,009.60 (-0.31% on day)

Week Open

Rs.2,135.40

Week Close

Rs.2,009.60Read full news article

RPG Life Sciences Ltd is Rated Sell

2026-01-30 10:10:03

RPG Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

RPG Life Sciences Ltd Downgraded to Sell as Quality Metrics Weaken

2026-01-29 08:00:10

RPG Life Sciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen its quality rating downgraded from 'Good' to 'Average' as of 16 January 2026, prompting a shift in its Mojo Grade from Hold to Sell. This change reflects a nuanced deterioration in several fundamental business parameters, despite the company’s strong historical returns and robust capital efficiency metrics.

Read full news article

Are RPG Life Sciences Ltd latest results good or bad?

2026-01-28 19:17:18

RPG Life Sciences Ltd's latest financial results for Q3 FY26 indicate a notable shift in operational performance. The company reported net sales of ₹180.03 crores, reflecting a marginal decline of 0.91% from the previous quarter. This stability in revenue contrasts sharply with the significant drop in net profit, which fell to ₹22.13 crores, marking a contraction of 39.95% quarter-on-quarter. The profit after tax (PAT) margin also experienced a substantial decrease, dropping to 12.29%, down from 20.28% in the prior quarter. The operating profit showed a slight improvement, with an operating margin of 22.09%, which is an increase of 61 basis points from the previous quarter. However, this positive aspect is overshadowed by the dramatic decline in gross profit margin, which fell to 19.16%, representing a significant compression of 1,093 basis points. This decline raises concerns regarding the company's prici...

Read full news article

RPG Life Sciences Ltd Hits Intraday Low Amid Price Pressure

2026-01-28 09:47:03

RPG Life Sciences Ltd experienced a significant intraday decline on 28 Jan 2026, touching a low of Rs 1,912.7, reflecting an 8.88% drop from previous levels. The stock underperformed its sector and broader market indices, continuing a three-day losing streak amid persistent selling pressure and subdued market sentiment.

Read full news article

RPG Life Sciences Q3 FY26: Profit Plunges 40% as Margin Pressures Mount

2026-01-27 22:30:55

RPG Life Sciences Limited reported a sharp decline in profitability for the third quarter of FY2026, with net profit tumbling 39.95% quarter-on-quarter to ₹22.13 crores, down from ₹36.85 crores in Q2 FY26. The Mumbai-based pharmaceutical company, with a market capitalisation of ₹3,483 crores, witnessed its stock decline 2.16% to ₹2,089.30 following the results announcement, reflecting investor concerns over deteriorating margins and sequential profit compression despite stable revenue performance.

Read full news article

RPG Life Sciences Declines 7.32%: Technical Downturn and Valuation Concerns Shape Week

2026-01-24 17:09:31

Key Events This Week

19 Jan: Downgrade to Sell rating by MarketsMOJO citing bearish technicals and valuation concerns

19 Jan: Technical momentum shifts to bearish with multiple indicators signalling weakness

22 Jan: Minor recovery with a 0.30% gain amid broader market rebound

23 Jan: Sharp decline of 3.20% on heavy volume closes the week lower

Week Open

Rs.2,295.45

Read full news article

Why is RPG Life Sciences Ltd falling/rising?

2026-01-24 00:50:35

Recent Price Movement and Market Context

The stock’s downward trajectory over the past week and month has been pronounced, with losses of 7.22% and 9.53% respectively, significantly exceeding the Sensex’s declines of 2.43% and 4.66% over the same periods. Year-to-date, RPG Life Sciences has fallen 7.87%, nearly double the Sensex’s 4.32% drop. Even over the last year, the stock has marginally declined by 1.33%, contrasting with the Sensex’s 6.56% gain. Despite this, the company’s longer-term performance remains robust, with three- and five-year returns of 148.29% and 380.94%, far outpacing the benchmark’s 33.80% and 66.82% respectively.

On the day of the decline, the stock underperformed its sector by 2.02%, hitting an intraday low of ₹2,125.05, a 3.67% drop from the pr...

Read full news article

When is the next results date for RPG Life Sciences Ltd?

2026-01-21 23:16:21

The next results date for RPG Life Sciences Ltd is scheduled for January 27, 2026....

Read full news article

View All News